Francesco Buccisano
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications
RBC depletion with Gelofusine in allogeneic hematopoietic stem cell transplantation.
Journal: Transfusion
Published: July 15, 2026
Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial.
Journal: American journal of hematology
Published: May 25, 2026
Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments.
Journal: European journal of haematology
Published: May 04, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.
Journal: British journal of haematology
Published: February 25, 2026
Diving into the transcriptional landscape of leukemic stem cells in acute myeloid leukemia at single-cell resolution.
Journal: Journal of cancer research and clinical oncology
Published: February 23, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.
Journal: Cancers
Published: December 28, 2025
Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex-Stratified Analysis of the GIMEMA AML1310 Trial.
Journal: American journal of hematology
Published: November 21, 2025
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.
Journal: Cancer medicine
Published: October 07, 2025
Measurable residual disease as an actionable biomarker in acute myeloid leukemia. Ready or not?
Journal: Current opinion in oncology
Published: October 01, 2025
Last Updated: 09/26/2026